|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00455832 |
|
Date of registration:
|
02/04/2007 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
IRIS |
|
Scientific title:
|
Influence of Ribavirin and Interferon on Semen Quality, IRIS Study |
|
Date of first enrolment:
|
November 2006 |
|
Target sample size:
|
23 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00455832 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
Robert J de Knegt, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Foundation for Liver Research |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Written informed consent
- Treatment with peginterferon and ribavirin in the presence of a chronic Hepatitis C
infection
Exclusion Criteria:
- Preexisting semen abnormalities.
- Concurrent use of drugs influencing sperm concentration,motility and morphology.
- Less then one million spermatozoa/ml in semen at screening.
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Sperm Motility (Focus of Study)
|
|
Intervention(s)
|
|
Procedure: peginterferon alpha and ribavirin
|
|
Secondary ID(s)
|
|
IRIS Study
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|